• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and rearrangement.

作者信息

Yan Yiru, Qu Shiqiang, Liu Jinqin, Li Chengwen, Yan Xiao, Xu Zefeng, Qin Tiejun, Jia Yujiao, Pan Lijuan, Gao Qingyan, Jiao Meng, Li Bing, Gale Robert Peter, Xiao Zhijian

机构信息

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, P.R. China.

Tianjin Institutes of Health Science, Tianjin, P.R. China.

出版信息

Leuk Lymphoma. 2023 Sep;64(9):1605-1610. doi: 10.1080/10428194.2023.2226277. Epub 2023 Jun 24.

DOI:10.1080/10428194.2023.2226277
PMID:37354441
Abstract
摘要

相似文献

1
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and rearrangement.奥雷巴替尼用于治疗与嗜酸性粒细胞增多和重排相关的髓系/淋系肿瘤。
Leuk Lymphoma. 2023 Sep;64(9):1605-1610. doi: 10.1080/10428194.2023.2226277. Epub 2023 Jun 24.
2
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.用FGFR1抑制剂治疗伴有FGFR1重排的髓系/淋系肿瘤。
Ann Oncol. 2018 Aug 1;29(8):1880-1882. doi: 10.1093/annonc/mdy173.
3
Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.伴有嗜酸性粒细胞增多和 BCR/FGFR1 重排的髓系/淋巴肿瘤，伴向皮质 T 淋巴母细胞淋巴瘤和红系前体细胞转化：一例报告。
J Med Case Rep. 2023 Jan 26;17(1):39. doi: 10.1186/s13256-022-03722-y.
4
[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].伴有嗜酸性粒细胞增多及血小板衍生生长因子受体α（PDGFRA）、血小板衍生生长因子受体β（PDGFRB）或成纤维细胞生长因子受体1（FGFR1）异常的髓系和淋巴系肿瘤
Zhonghua Bing Li Xue Za Zhi. 2012 Nov;41(11):779-83. doi: 10.3760/cma.j.issn.0529-5807.2012.11.018.
5
Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.与嗜酸性粒细胞增多及血小板衍生生长因子受体α（PDGFRA）和成纤维细胞生长因子受体1（FGFR1）同时重排相关的髓系/淋系肿瘤：1例极罕见的儿科病例
Pediatr Blood Cancer. 2023 Oct;70(10):e30507. doi: 10.1002/pbc.30507. Epub 2023 Jun 19.
6
Myeloid/lymphoid neoplasm with FGFR1 rearrangement.
Blood. 2021 Sep 9;138(10):912. doi: 10.1182/blood.2021012168.
7
Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.伴有FGFR1异常、呈现三系原始细胞及RUNX1重排的髓系和淋系肿瘤：一例报告并文献复习
Am J Clin Pathol. 2015 May;143(5):738-48. doi: 10.1309/AJCPUD6W1JLQQMNA.
8
Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission.
Pediatr Blood Cancer. 2024 Jan;71(1):e30721. doi: 10.1002/pbc.30721. Epub 2023 Oct 13.
9
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
Am J Hematol. 2023 Dec;98(12):1959-1962. doi: 10.1002/ajh.27026. Epub 2023 Jul 12.
10
Myeloid/lymphoid neoplasm with a novel cryptic rearrangement presenting as de novo acute leukemias.
Leuk Lymphoma. 2023 Dec;64(14):2338-2342. doi: 10.1080/10428194.2023.2262640. Epub 2023 Dec 25.

引用本文的文献

1
[Guideline of the diagnosis and treatment of eosinophilic disorders (2024)].[嗜酸性粒细胞相关疾病的诊断和治疗指南（2024年）]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):1-7. doi: 10.3760/cma.j.cn121090-20231222-00334.
2
Hematological Neoplasms with Eosinophilia.伴有嗜酸性粒细胞增多的血液系统肿瘤
Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337.